GT Biopharma, Inc. Earnings Per Share Diluted

Quick Answer

GT Biopharma, Inc. reported Earnings Per Share Diluted of $6.68 (loss) per share for the year ending 2025.

  • GT Biopharma, Inc. showed an increase of +3.7% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from GT Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2012: $0.00 per share | Q2 2012: $0.01 (loss) per share | Q1 2013: $0.00 per share | Q2 2013: $0.00 per share | Q1 2014: $0.00 per share | Q2 2014: $0.00 per share | Q3 2014: $0.01 (loss) per share | Q1 2015: $8.61 (loss) per share | Q2 2015: $4,907,238.00 per share | Q3 2015: $0.71 per share | Q1 2016: $1.49 per share | Q2 2016: $18.22 per share | Q3 2016: $39.65 (loss) per share | Q1 2017: $26.36 (loss) per share | Q2 2017: $479,053.00 per share | Q3 2017: $8.15 (loss) per share | Q1 2018: $0.20 (loss) per share | Q2 2018: $50,117,977.00 per share | Q3 2018: $4.70 (loss) per share | Q1 2019: $0.09 (loss) per share | Q1 2020: $0.02 (loss) per share | Q2 2022: $0.10 (loss) per share | Q3 2022: $0.22 (loss) per share | Q1 2023: $0.21 (loss) per share | Q2 2023: $1.49 (loss) per share | Q3 2023: $1.77 (loss) per share | Q1 2024: $1.64 (loss) per share | Q2 2024: $2.17 (loss) per share | Q3 2024: $1.53 (loss) per share | Q1 2025: $0.33 (loss) per share | Q2 2025: $10.92 (loss) per share | Q3 2025: $1.04 per share.
  • Over the full 7 years of available data (2016 to 2025), GT Biopharma, Inc.'s Earnings Per Share Diluted has declined by 105.6%.
  • Historical annual values: Fiscal year 2025: $6.68 (loss) per share | Fiscal year 2024: $6.94 (loss) per share | Fiscal year 2023: $5.64 (loss) per share | Fiscal year 2022: $19.66 (loss) per share | Fiscal year 2018: $5.16 (loss) per share | Fiscal year 2017: $8.60 (loss) per share | Fiscal year 2016: $119.91 per share.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: